We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharmaceutical Cost Cutting Still Includes R&D for Some
Pharmaceutical Cost Cutting Still Includes R&D for Some
November 7, 2013
Fitch Rulings believes that brand pharmaceutical companies such as Pfizer, Merck and Bristol-Myers Squibb are in for more rounds of cost-cutting measures in the near future. India InfoLine
